Bender Robert & Associates Has $29.99 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bender Robert & Associates decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 88,904 shares of the medical equipment provider’s stock after selling 427 shares during the period. Intuitive Surgical makes up about 7.6% of Bender Robert & Associates’ investment portfolio, making the stock its 3rd largest position. Bender Robert & Associates’ holdings in Intuitive Surgical were worth $29,993,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. RB Capital Management LLC lifted its stake in shares of Intuitive Surgical by 4.4% during the 1st quarter. RB Capital Management LLC now owns 1,735 shares of the medical equipment provider’s stock worth $523,000 after acquiring an additional 73 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. increased its stake in Intuitive Surgical by 0.6% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 946,709 shares of the medical equipment provider’s stock worth $285,603,000 after purchasing an additional 5,233 shares during the period. Baird Financial Group Inc. lifted its position in shares of Intuitive Surgical by 2.3% during the first quarter. Baird Financial Group Inc. now owns 21,089 shares of the medical equipment provider’s stock worth $6,362,000 after purchasing an additional 481 shares during the last quarter. Brown Brothers Harriman & Co. boosted its stake in shares of Intuitive Surgical by 576.7% during the first quarter. Brown Brothers Harriman & Co. now owns 406 shares of the medical equipment provider’s stock valued at $122,000 after purchasing an additional 346 shares during the period. Finally, Covestor Ltd grew its holdings in shares of Intuitive Surgical by 50.4% in the first quarter. Covestor Ltd now owns 418 shares of the medical equipment provider’s stock worth $126,000 after purchasing an additional 140 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several research firms have issued reports on ISRG. Citigroup boosted their price objective on shares of Intuitive Surgical from $428.00 to $462.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd. StockNews.com downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Thursday, February 29th. Piper Sandler lifted their price objective on Intuitive Surgical from $325.00 to $425.00 and gave the company an “overweight” rating in a report on Wednesday, January 24th. Truist Financial upped their price target on shares of Intuitive Surgical from $390.00 to $435.00 and gave the stock a “buy” rating in a research report on Wednesday, January 24th. Finally, Stifel Nicolaus boosted their price objective on shares of Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a research note on Monday, April 8th. Five investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $375.70.

Insider Activity

In related news, SVP Mark Brosius sold 196 shares of the firm’s stock in a transaction on Tuesday, March 5th. The stock was sold at an average price of $400.00, for a total value of $78,400.00. Following the completion of the transaction, the senior vice president now owns 1,842 shares in the company, valued at approximately $736,800. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, VP Marshall Mohr sold 108,790 shares of the company’s stock in a transaction on Wednesday, February 28th. The shares were sold at an average price of $385.08, for a total value of $41,892,853.20. Following the sale, the vice president now directly owns 26,877 shares of the company’s stock, valued at approximately $10,349,795.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Mark Brosius sold 196 shares of the business’s stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total transaction of $78,400.00. Following the transaction, the senior vice president now owns 1,842 shares of the company’s stock, valued at $736,800. The disclosure for this sale can be found here. Insiders have sold 248,418 shares of company stock valued at $95,927,097 over the last ninety days. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Stock Down 0.4 %

Shares of ISRG traded down $1.54 during mid-day trading on Thursday, hitting $372.63. 2,287,472 shares of the company traded hands, compared to its average volume of 1,644,605. The company has a market capitalization of $132.08 billion, a PE ratio of 74.39, a price-to-earnings-growth ratio of 5.88 and a beta of 1.36. The business has a 50 day moving average of $387.56 and a 200 day moving average of $342.39. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.10. The company had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.87 billion. Intuitive Surgical had a net margin of 25.24% and a return on equity of 13.11%. Intuitive Surgical’s revenue was up 11.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.00 EPS. As a group, research analysts expect that Intuitive Surgical, Inc. will post 4.93 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.